ABTAbbott Laboratories

$114.10

What is the market doing?

What the tape says about ABT

Abbott Laboratories is −11% over the past year while the S&P 500 is +23%: 34 points behind the market. Through the fall, its own insiders bought $3.9M more stock than they sold.

−11%

1-year return · S&P 500 +23%

vs 200-day average
+5.5%

vs 200-day average · close to trend

RSI (14)
72

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
−15%

Below its 52-week high

2024-08-05$82.56 – $136.78 · dashed line: 200-day average2026-08-26
Details
Last close2026-08-26
$114.10
1 monthS&P 500 +3.7%
+13%
1 yearS&P 500 +23%
−11%
5 yearsS&P 500 +87%
+3.2%
vs 50-day average$99.44
+15%
52-week high
$134.49
52-week low
$82.56
Annualised volatility
24%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
$3.9M
Calendar-year price return
YearReturn
2026 (year to date)−7.9%
2025+13%
2024+4.8%
2023+2.3%
2022−21%
2021+31%
2020+28%
2019+22%
2018+29%
2017+52%
Average return by calendar month, 2016–2026
MonthYearsPositiveAverage
Jan108 of 10+3.1%
Feb105 of 10+0.25%
Mar103 of 10−1.9%
Apr103 of 10+0.17%
May105 of 10−0.49%
Jun106 of 10+2.0%
Jul1110 of 11+5.5%
Aug117 of 11+1.4%
Sep105 of 10−0.39%
Oct104 of 10−0.99%
Nov108 of 10+3.9%
Dec107 of 10+1.5%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.